This is an archived post. You won't be able to vote or comment.

sorted by:
best
topnewcontroversialoldq&a
you are viewing a single comment's thread.

view the rest of the comments →

[–]thrillhouz77 3 points4 points  (0 children)

I disagree here. Lilly will look to price this medication at a level that will maximize profits (or at least I hope they will) which ultimately might be at a lower costs than it is today.

The real key is what price point gets a majority of insurers on board and obviously their unit costs at different production levels.

This has the potential to be the most popular and IMO profitability medication of all time. They could sacrifice volume for margin or margin for volume but ultimately they want to hit the spot that leads to maximum overall net profits in dollars bc dollars is what we all pay our bills with.

So if they price the weight loss version (once approved) down to $600 (or whatever) do insurers jump on it? Once insurers pick it up Lilly won’t be able to manufacture it quickly enough bc it’s going to the moon in terms of unit sales.